Literature DB >> 210355

Pituitary effects of somatostatin.

R Hall, M Snow, M Scanlon, B Mora, A Gomez-Pan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210355     DOI: 10.1016/0026-0495(78)90055-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  5 in total

1.  Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.

Authors:  V Schusdziarra; D Grube; H Seifert; J Galle; H Etzrodt; W Beischer; O Haferkamp; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1983-07-15

2.  Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995.

Authors:  K Kusuhara; M Kusunoki; T Okamoto; Y Sakanoue; J Utsunomiya
Journal:  Int J Colorectal Dis       Date:  1992-12       Impact factor: 2.571

3.  Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.

Authors:  H Ahlman; L Ahlund; A Dahlström; O Nilsson; G Skolnik; L E Tisell; U Tylén
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

Review 4.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

5.  GH secretory dynamics and responsiveness to SMS 201-995 treatment in acromegaly.

Authors:  S W Kim; S Y Kim; I M Yang; J W Kim; Y S Kim; K W Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1988-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.